Wolfgang Seidel
Vice President Commercial Development & Operations
Wolfgang Seidel studied chemistry and biology at the University of Münster (Germany), where he obtained his doctorate in organic chemistry in 1980. After a postdoctorate in Zürich, he joined Bayer AG as a clinical chemist in 1981, and was subsequently appointed project manager for international clinical studies. In 1988, he became a director of Bayer´s therapeutic monoclonal antibody development program in Berkeley (California). Since 1992, Wolfgang Seidel fulfilled several functions in Bayer´s International Pharmaceutical Sales & Marketing Organization, before becoming responsible for the German Biological Products business where he was a member of the Bayer Vital Executive Committee. Since 2005, he has assumed responsibility for Business Development and since April 2007 all Commercial Development and Operations at Innogenetics.